ATyr Pharma, Inc. (NASDAQ:ATYR) Is a Favorite Amongst Institutional Investors Who Own 57%

Yahoo FinanceDec 19 22:06

ATyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 17 21:00

Express News | ATyr Pharma Announces the Appointment of Eric Benevich to Its Board of Directors

BreakingsDec 13 05:00

JonesTrading Maintains ATyr Pharma(ATYR.US) With Buy Rating, Maintains Target Price $22

Futu NewsDec 11 00:31 · Ratings

H.C. Wainwright Maintains ATyr Pharma(ATYR.US) With Buy Rating, Maintains Target Price $35

Futu NewsDec 10 23:31 · Ratings

Positive Outlook for ATyr Pharma: Favorable Phase 3 Progress and Competitive Advantage Highlight Buy Rating

TipRanksDec 10 23:25 · Ratings